Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A RANDOMIZED COMPARATIVE SPLIT FACE STUDY TO EVALUATE THE EFFICACY AND TOLERANCE OF AN EYELID BALM IN COMBINATION WITH A TOPICAL CALCINEURIN INHIBITOR TREATMENT - TACROLIMUS 0.1 % - IN SUBJECTS WITH ATOPIC EYELID DERMATITIS

NCT07819071 is registered in ClinicalTrials.gov with Pierre Fabre Dermo Cosmetique as lead sponsor.

NCT NCT07819071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07819071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A RANDOMIZED COMPARATIVE SPLIT FACE STUDY TO EVALUATE THE EFFICACY AND TOLERANCE OF AN EYELID BALM IN COMBINATION WITH A TOPICAL CALCINEURIN INHIBITOR TREATMENT - TACROLIMUS 0.1 % - IN SUBJECTS WITH ATOPIC EYELID DERMATITIS
Lead sponsor
Pierre Fabre Dermo Cosmetique
Phase
Not applicable
Overall status
Completed
Start date
November 3, 2025
Completion date
January 10, 2026
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis (ad)